By Drug Target Review2025-02-06T13:17:31
Study reveals how type 2 diabetes accelerates cognitive decline by damaging white matter in the brain. Sam Hashemi at Prenuvo explains how advanced AI and whole-body MRI technology are opening new possibilities for early intervention.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2024-03-08T10:00:25
Sponsored by Molecular Devices
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2023-09-27T13:56:39
Sponsored by Euretos
2024-02-01T11:52:50
Sponsored by Leica Microsystems
Site powered by Webvision Cloud